165 related articles for article (PubMed ID: 14975712)
1. Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock.
Collin M; Abdelrahman M; Thiemermann C
Eur J Pharmacol; 2004 Feb; 486(2):233-5. PubMed ID: 14975712
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-gamma antagonist.
Sivarajah A; McDonald MC; Thiemermann C
J Pharmacol Exp Ther; 2005 May; 313(2):896-901. PubMed ID: 15734901
[TBL] [Abstract][Full Text] [Related]
3. 15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria.
Dugo L; Collin M; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Sep; 498(1-3):295-301. PubMed ID: 15364008
[TBL] [Abstract][Full Text] [Related]
4. The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock.
Collin M; Thiemermann C
Eur J Pharmacol; 2003 Aug; 476(3):257-8. PubMed ID: 12969773
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma.
Siddiqui AM; Cui X; Wu R; Dong W; Zhou M; Hu M; Simms HH; Wang P
Crit Care Med; 2006 Jul; 34(7):1874-82. PubMed ID: 16715036
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia.
Collin M; Murch O; Thiemermann C
Crit Care Med; 2006 Apr; 34(4):1131-8. PubMed ID: 16484917
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of ghrelin on left ventricular remodeling in spontaneously hypertensive rats is associated with the peroxisome proliferator-activated receptor gamma-dependent pathway.
Li Z; Zhu XY; Li M; Bai YL; Hu J
Chin Med J (Engl); 2008 Nov; 121(22):2299-304. PubMed ID: 19080336
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
Bernardo A; Bianchi D; Magnaghi V; Minghetti L
J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
[TBL] [Abstract][Full Text] [Related]
11. Salutary effects of androstenediol on hepatic function after trauma-hemorrhage are mediated via peroxisome proliferators-activated receptor gamma.
Shimizu T; Szalay L; Hsieh YC; Choudhry MA; Bland KI; Chaudry IH
Surgery; 2005 Aug; 138(2):204-11. PubMed ID: 16153428
[TBL] [Abstract][Full Text] [Related]
12. [Effect of peroxisome proliferation activated receptor-gamma on neuronal cell death induced by hypoxia and ischemia in rats in vitro and in vivo].
Zhang YQ; Zhang YN; Wu J; Zhu XY; Xu CQ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):684-8. PubMed ID: 15932732
[TBL] [Abstract][Full Text] [Related]
13. A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.
Shimizu T; Szalay L; Hsieh YC; Suzuki T; Choudhry MA; Bland KI; Chaudry IH
Ann Surg; 2006 Jul; 244(1):131-8. PubMed ID: 16794398
[TBL] [Abstract][Full Text] [Related]
14. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L
J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
16. Altered PPARgamma expression and activation after transient focal ischemia in rats.
Victor NA; Wanderi EW; Gamboa J; Zhao X; Aronowski J; Deininger K; Lust WD; Landreth GE; Sundararajan S
Eur J Neurosci; 2006 Sep; 24(6):1653-63. PubMed ID: 17004929
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury.
Cuzzocrea S
Vascul Pharmacol; 2004 Jul; 41(6):187-95. PubMed ID: 15653094
[TBL] [Abstract][Full Text] [Related]
19. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
